Page 60 - ஒன்றுபட்டது மாநிலங்களில் கம்பி குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RushNet Inc. Cancellation of Proposed Reverse Split ACCESSWIRE ALPHARETTA, GA / ACCESSWIRE / June 9, 2021 / RushNet, Inc. (OTC PINK:RSHN) ( RushNet ) with merger/acquisition target heliosDX, is pleased to announce the official cancelation of the proposed Reverse Split (RS). The company will file with the Colorado Secretary of State to reflect such cancelation. About HeliosDx: heliosDX is a National Independent Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting

United statesWilliam hinmanJay claytonDivision of corporationNational independent clinical reference laboratoryRushnet incReverse splitColorado secretaryHigh complexity urine drug testingBehavioral drug testingAllergy droplet cardsOral fluidsInfectious diseaseUnder developmentPrivate securities litigation reform actCorporation finance